Trial
NCT03799003
A Study of ASP1951 in Subjects With Advanced Solid Tumors
Phase ITERMINATEDEFFICACY/FUTILITYConfidence: MEDIUM
Sponsor
Astellas Pharma Global Development, Inc.
Collaborators
Merck Sharp & Dohme LLC
Condition
Advanced Solid Tumors
Intervention
ASP1951
Why stopped
Study was terminated for lack of efficacy.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-11-01